Results 161 to 170 of about 8,927 (183)

Secukinumab

Reactions Weekly, 2019
  +9 more sources

Secukinumab

Reactions Weekly, 2018
  +9 more sources

Secukinumab

Reactions Weekly, 2020
  +7 more sources

Secukinumab

Reactions Weekly, 2023
  +5 more sources

Secukinumab

Reactions Weekly, 2021
  +5 more sources

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

Clinical, Cosmetic and Investigational Dermatology, 2023
Fabrizio Martora, Matteo Megna, TERESA Battista   +2 more
exaly  

Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis

Journal of Dermatological Treatment, 2020
Andreas Pintér, Sascha Gerdes, Charis Papavassilis   +2 more
exaly  

Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability

Patient Preference and Adherence, 2023
Michał Niedźwiedź, Aleksandra Lesiak   +1 more
exaly  

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

Expert Opinion on Biological Therapy, 2020
Marco Galluzzo, Simone D'Adamio, Dionisio Silvaggio   +2 more
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce Kirkham   +2 more
exaly